Medically reviewed by Johnstone M. Kim, MD Key Takeaways Age-related macular degeneration (AMD) is a leading cause of vision ...

Traditional angle closure glaucoma management, including LPI, is being challenged due to limited evidence of efficacy in preventing visual field loss. The ZAP study suggests LPI's limited prophylactic ...

The cause of glaucoma is unknown, but it is accompanied by high eye pressure. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Glaucoma is a group ...

Please provide your email address to receive an email when new articles are posted on . A 73-year-old white woman was referred to the retina service at the New England Eye Center for consideration of ...

A retrospective study found that 26% of eyes with acute primary angle closure (APAC) were resolved after initial medical treatment. A study published in the Journal of Ophthalmology found that 26% of ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

Please provide your email address to receive an email when new articles are posted on . Late posterior subcapsular cataract appeared to lower the risk. “The lack of longitudinal data on [primary angle ...

The MarketWatch News Department was not involved in the creation of this content.-- The first VisiPlate surgery in the US for the SAPPHIRE Trial was performed by Dr. Snyder of Sac ...

During his recent visit to Bangladesh, Assoc Prof Shamira Perera, Head of the Glaucoma Department at the Singapore National ...